Wockhardt, one of India’s largest drug makers, is seeking shareholders’ nod to raise up to Rs 1,000 crore via issue of securities. The company is seeking the approval via a postal ballot for raising additional capital by way of one or more public or private offerings including through a qualified institutions placement (QIP). The shareholders can approve the resolution through e-voting or physical postal ballot form. The voting period for the company’s shareholders begins on May 10 and ends on June 8, 2017.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.